Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentBeginning Cash BalanceBeginning Cash BalanceCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

Guided Therapeutics (GTHP) Free Cash Flow (2016 - 2025)

Guided Therapeutics' Free Cash Flow history spans 15 years, with the latest figure at -$291000.0 for Q4 2025.

  • On a quarterly basis, Free Cash Flow rose 12.35% to -$291000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.1 million, a 4.56% increase, with the full-year FY2025 number at -$1.1 million, up 4.38% from a year prior.
  • Free Cash Flow hit -$291000.0 in Q4 2025 for Guided Therapeutics, down from -$277000.0 in the prior quarter.
  • Over the last five years, Free Cash Flow for GTHP hit a ceiling of $155000.0 in Q4 2021 and a floor of -$744000.0 in Q3 2021.
  • Historically, Free Cash Flow has averaged -$352450.0 across 5 years, with a median of -$334000.0 in 2023.
  • Biggest five-year swings in Free Cash Flow: soared 146.83% in 2021 and later tumbled 320.65% in 2022.
  • Tracing GTHP's Free Cash Flow over 5 years: stood at $155000.0 in 2021, then tumbled by 320.65% to -$342000.0 in 2022, then grew by 1.75% to -$336000.0 in 2023, then grew by 1.19% to -$332000.0 in 2024, then increased by 12.35% to -$291000.0 in 2025.
  • Business Quant data shows Free Cash Flow for GTHP at -$291000.0 in Q4 2025, -$277000.0 in Q3 2025, and -$169000.0 in Q2 2025.